Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
05/2012
05/24/2012US20120126184 Surface-modified pigment compositions
05/23/2012EP2455367A1 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
05/23/2012CN1997645B Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors
05/23/2012CN102471289A 4-((1r,3s)-6-氯-3-苯基-茚满-1-基)-1,2,2-三甲基-哌嗪和1-((1r,3s)-6-氯-3-苯基-茚满-1-基)-3,3-二甲基-哌嗪的制备 4 - ((1r, 3s) -6- chloro-3-phenyl - indan-l-yl) -1,2,2-trimethyl - piperazine and 1 - ((1r, 3s) -6- chloro-3-phenyl - indan-l-yl) -3,3-dimethyl - piperazine was prepared
05/23/2012CN102464630A 含氮杂环取代的苯甲酰基类化合物及其应用 Nitrogen-containing heterocyclic compounds substituted benzoyl and Applications
05/23/2012CN102464612A 含哌嗪氨基甲酸酯的二卤丙烯醚类化合物与应用 Piperazine-containing urethane-dihalo ether compound of propylene and Applications
05/23/2012CN101973945B Synthesis method of tetraarylpyrazine compounds
05/23/2012CN101712655B Acetamide derivative and application thereof in pharmacy
05/23/2012CN101514192B Quinoxalinone derivative with activity for reversing tumor cell multidrug resistance and preparation method thereof
05/23/2012CN101511789B 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists
05/23/2012CN101061098B Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
05/22/2012US8183372 Substituted 9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydor-1H-pyrido[1,2-a]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazines
05/22/2012US8183371 Pyrazines as delta opioid receptor modulators
05/22/2012US8183244 Glycine transporter-1 inhibitors
05/22/2012CA2683696C Dpp-iv inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating a diabetes or an obesity
05/18/2012WO2012063931A1 Pyrazino[2,3-d]isooxazole derivative
05/18/2012WO2012063843A1 Halogenated indenones and method for producing optically active indanones or optically active indanols by using same
05/18/2012WO2012062531A1 Herbicidal compounds
05/18/2012WO2012062412A1 Non metal tanning
05/18/2012WO2012062210A1 Compound for increasing kinase active and application thereof
05/18/2012CA2816753A1 N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases
05/18/2012CA2816687A1 Pyrazino[2,3-d]isooxazole derivative
05/18/2012CA2816000A1 Drug derivatives
05/18/2012CA2815578A1 Herbicidal compounds
05/17/2012US20120123117 Organometallic Complex, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Including the Organometallic Complex
05/17/2012US20120123026 Functionalized compositions for improved immobilization
05/17/2012US20120122884 Compounds useful as inhibitors of atr kinase
05/17/2012US20120122868 Apaf-1 inhibitor compounds
05/17/2012US20120122837 Inhibitors of fatty acid binding protein
05/16/2012EP2452935A2 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
05/16/2012EP2451789A1 Manufacture of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine
05/16/2012EP1934233B1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
05/16/2012CN102459198A Crystals
05/16/2012CN102459197A 适用于治疗响应血清素5-HT<sub>6</sub>受体的调节的病症的N-苯基-(哌嗪基或高哌嗪基)-苯磺酰胺或苯磺酰基-苯基-(哌嗪或高哌嗪)化合物 Applicable to the treatment response serotonin 5-HT <sub> 6 </ sub> receptor modulated disorders of N- phenyl - (piperazinyl or homopiperazinyl) - benzenesulfonamide or benzenesulfonyl - phenyl - (piperazine or homopiperazine) compound
05/16/2012CN102459178A 2,5-disubstituted arylsulfonamide ccr3 antagonists
05/16/2012CN102459177A 2,5-disubstituted arylsulfonamide ccr3 antagonists
05/16/2012CN102458659A 不对称氢化催化剂 Asymmetric hydrogenation catalyst
05/15/2012US8178527 Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
05/15/2012US8178216 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative
05/10/2012US20120116083 Heteroaromatic pyrazinoylguanidine sodium channel blockers
05/10/2012US20120116080 Process for the stereoselective preparation of bicyclic heterocycles
05/10/2012US20120115874 Pyrazine derivatives, process for manufacture and use thereof
05/10/2012US20120115841 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
05/10/2012US20120115818 Synthesis of tetracyclines and intermediates thereto
05/10/2012US20120115726 Herbicidal compounds
05/10/2012DE102010048800A1 Chinoxalinderivate Quinoxaline derivatives
05/09/2012EP2450350A1 3-Pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as HDL-cholesterol raising agents
05/09/2012EP2450347A1 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
05/09/2012EP2448582A1 Therapeutic compounds and compositions
05/09/2012EP1644342B1 Arylpyrimidines useful for the treatment of sex hormone-related conditions such as endometriosis, prostate cancer and the like
05/09/2012CN1729312B Mixture of oligomeric phenazinium compounds and acid bath for electrolytically depositing a copper deposit
05/09/2012CN102448937A Aryl Substituted Carboxamide Derivatives As Calcium Or Sodium Channel Blockers
05/09/2012CN102448936A Heterocyclic antiviral compounds
05/09/2012CN102443170A Thermosetting polyphenylquinoxaline resin, its preparation method and application
05/09/2012CN102442969A Butyne ether compound and application thereof
05/09/2012CN102442968A Butylene ether compound and application thereof
05/09/2012CN102442967A Dichloropropylene compound and application thereof
05/09/2012CN102442956A Method for synthesizing mequindox
05/09/2012CN102442955A Dichloropropylene compound containing quinoxaline loop and application thereof
05/04/2012CA2817549A1 Acid gas absorbent composition
05/03/2012US20120108815 Bifunctional/polyfunctional dopamine d2/d3 agonist as neuroprotective agents for treatment of neurodegenerative diseases
05/03/2012US20120108677 Iminic monomers and polymers thereof
05/03/2012US20120108611 5, 6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108602 Carbamoyl Compounds as DGAT1 Inhibitors 190
05/03/2012US20120108494 Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof
05/03/2012US20120107830 Reagents for biomolecular labeling, detection and quantification employing raman spectroscopy
05/03/2012US20120107273 New piperazine compound and use thereof as a hcv polymerase inhibitor
05/03/2012US20120102826 Diesel fuel additive
05/02/2012EP2447254A1 Crystals
05/02/2012EP2445875A2 Heterocyclic antiviral compound
05/02/2012EP2445868A2 Novel biphenyl and phenyl-pyridine amides
05/02/2012EP1716851B1 Thioamides and salts thereof and cytokine production inhibitors containing both
05/02/2012CN102432554A Method for synthesizing D(-)-alpha-(4-ethyl-2,3-dioxypiperazine-1-methanamide) hydroxyphenylacetic acid (HO-EPCP)
05/01/2012US8168825 Amide derivatives, process for preparation thereof and use thereof as insecticide
05/01/2012US8168789 Organic amine salt of 6-fluoro-3-hydroxy-2-pyrazinecarbonitrile and method for producing the same
05/01/2012US8168654 Quinuclidine derivatives binding to mucarinic M3 receptors
05/01/2012US8168638 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
05/01/2012CA2517888C Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
04/2012
04/26/2012WO2012053606A1 Arylaminoheterocyclic carboxamide compound
04/26/2012WO2012052420A1 Method for preparing substituted n-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates n-(3-chloro-quinoxalin-2-yl)sulfonamides
04/26/2012WO2012052102A1 Quinoxaline derivates
04/26/2012US20120101427 Novel photosensitizer formulations for oral administration
04/26/2012US20120101278 Process for producing biaryl compound
04/26/2012US20120101276 Crystals
04/26/2012US20120101105 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
04/26/2012US20120101080 Composition for treatment of tuberculosis
04/26/2012US20120100078 Pyrazine Derivatives and Uses Thereof in Renal Monitoring
04/26/2012CA2815127A1 Quinoxaline derivatives
04/26/2012CA2815107A1 Method for preparing substituted n-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates n-(3-chloro-quinoxalin-2-yl)sulfonamides
04/26/2012CA2814378A1 Antimicrobial polyether and polyol compounds
04/25/2012EP2444397A1 Heteroaryl-ureas and their use as glucokinase activators
04/25/2012EP2444120A1 Spirocyclic amiloride analogues as ENac blockers
04/25/2012EP2443096A1 Pyrazine carboxamides as inhibitors of dgat1
04/25/2012CN101849953B 炎症性细胞因子产生游离抑制剂 Inflammatory cytokine production inhibitor free
04/24/2012US8163905 Compounds and their uses 708
04/24/2012US8163751 Acylated indanyl amines and their use as pharmaceuticals
04/24/2012US8163735 Sulfonamide compounds as cysteine protease inhibitors
04/24/2012CA2525373C Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
04/24/2012CA2524054C Immunosuppressant compounds and compositions
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 187